Biotherapeutics maker Vital Therapies raises $14 million in an equity financing round ahead of its revived initial public offering.
Bio-artificial liver maker Vital Therapies is prepared to take another run at its initial public offering, months after deciding to put off the IPO to await more favorable market conditions.
The California biotech company filed updated registration statements signaling its intent to launch the IPO, wiping clean the pricing set in November 2013. The new offering cap and per-share pricing have yet to be announced.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/OmaWpN
Cap comentari:
Publica un comentari a l'entrada